Global Delirium
Market Report
2025
Delirium Market Report 2025 (Global Edition)
The Global Delirium Market size is USD 0.248 billion in 2022 and will grow at a compound annual growth rate (CAGR) of 6.10% from 2023 to 2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
|
Rating: 4.8 | Review: 6
Share your contact details to receive free updated sample copy/pages of the recently published edition of Delirium Market Report 2024.
Global Delirium Market Report 2024 Market Size Split by Disease Type (Hyperactive delirium, Hypoactive delirium, Mixed delirium), by End-Use (Hospitals, Speciality clinics), by Distribution channel (O...
According to Cognitive Market Research, the global delirium market size is USD 0.248 billion in 2022 and will grow at a compound annual growth rate (CAGR) of 6.10% from 2023 to 2030.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Delirium Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.1% |
| Market Split by Disease Type |
|
| Market Split by End-Use |
|
| Market Split by Distribution channel |
|
| Market Split by Route of administration |
|
| Market Split by Treatment |
|
| Market Split by Dosage Form |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Delirium industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Delirium Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Delirium Market Report Description
Introduction of Delirium
Delirium is a neurological illness that causes abnormalities in a person's mental capacity. It produces mental perplexity as well as emotional upheaval. Delirium can be induced by a variety of circumstances, including old age, pharmaceutical exposure, alcohol misuse, surgery or other medical operations, and exposure to poisonous or infectious agents, physical trauma, food, and other behavioural and occupational variables. Several factors are driving the market, including the rising prevalence of delirium in ICU patients, the need for new diagnostic tools, and the acknowledgement of delirium as a major healthcare issue.
Within 24 hours after admission, the prevalence of delirium is reported to be 10%-31% among hospitalized patients.4 The frequency among older patients is reported to be 15%-53% after surgery5 6 and 80% among those admitted to the ICU.5 Previous research has linked delirium to longer hospital stays, institutionalization, and increased mortality in non-surgical and surgical patients in general wards, emergency departments, and intensive care units (ICUs).
Delirium Market Size
Market driver of the Delirium Market
Key Driver for the Delirium Market
As the world's population ages, there is an increasing need for healthcare services, specialized care facilities, and pharmaceutical goods suited to the specific requirements of older persons. This demographic transition creates chances to expand healthcare infrastructure, such as hospitals, nursing homes, and home care services. Furthermore, the increased frequency of delirium, a prevalent illness among the aged that causes abrupt disorientation and cognitive impairment, needs the development of novel diagnostic techniques, therapeutic choices, and supportive care measures.
According to the World Health Organization (WHO), the worldwide geriatric population, which was anticipated to be around 524 million in 2010, is likely to increase to over 2 billion by 2050.
Market Dynamics of Delirium
-
The Lack of Non-Pharmacological Therapy Options Limits Market Growth
The primary method of treating delirium is to utilize drugs such as antipsychotics and sedatives. These pharmaceutical therapies, however, may have limits and significant negative effects. Non-pharmacological treatments, on the other hand, focus on environmental changes, cognitive stimulation, and supportive interventions to provide alternate and complementary ways to controlling delirium. Unfortunately, non-pharmacological options for delirium therapy are scarce and difficult to apply. This is due to a variety of causes, including a lack of defined practices, a lack of awareness among healthcare personnel, and resource limits in healthcare settings.
Impact of COVID-19 on the Delirium Market
The pandemic has created significant obstacles in controlling and treating delirium, particularly in hospital settings such as intensive care units (ICUs). The growing demand on healthcare systems, limited resources and the necessity to prioritize COVID-19 patients have all had an impact on delirium patients' overall treatment and attention. Furthermore, infection control techniques such as restricted visiting policies and isolation protocols have reduced social interaction and cognitive stimulation for patients, potentially worsening delirium symptoms.
We have various report editions of Delirium Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Competitive Landscape of Delirium Market
Leading market players are extensively spending in R&D to extend their product ranges, which will help the delirium market grow even further. Important market developments include new product releases, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other firms. To grow and thrive in a more competitive and increasing market setting, the delirium sector must provide cost-effective products.
December, 2020, The FDA granted Aurobindo Pharma final approval to manufacture and commercialize Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 200 g/50 mL and 400 g/100 mL Single Dose flexible containers (Bags).
September 2020, Dr. Reddy's Laboratories launched Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection form for sedation of first intubated and mechanically ventilated patients in an intensive care setting for the treatment of hyperactive delirium (agitation in delirium).
June 2021, The FDA has approved ALKERMES plc's LYBALVITM (olanzapine and samidorphan) for the acute treatment of mixed episodes, either as a monotherapy or as an addition to lithium or valproate.
Top Companies Market Share in Delirium Industry: (In no particular order of Rank)
- Dr Franz Kohler Chemie GmbH
- Gala BioPharma Ltd.
- Teva pharmaceuticals
- Mylan N.V.
- Pfizer Inc.
- Regenstrief Institute Inc
- Novartis AG
- Otsuka Pharmaceutical Co. Ltd.
- Bristol-Myers Squibb
- Fraser Health
- Zydus Cadila
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
The North America Delirium Market Dominate the Largest Share of Global Market
According to Cognitive Market Research, due to the localisation of novel therapeutic options, the North American delirium market will dominate this industry. Rising rates of suicide thoughts and mental health diseases in the region are fueling the region's increasing embrace of different innovations in mental health treatment choices. Better delirium treatment options are also in high demand as the general public's knowledge of mental health concerns grows in the aftermath of the COVID-19 epidemic. According to Cognitive Market Research, the United States has always been a leading player in the North American delirium market. Its excellent healthcare infrastructure, research skills, and emphasis on innovation all contribute to its industry supremacy.
Furthermore, because of an increase in the number of older individuals in numerous countries, including China and India, the Asia-Pacific Delirium Market is predicted to develop at the quickest CAGR from 2023 to 2032. The presence of generic manufacturers and the expansion of healthcare facilities in the area are expected to contribute to the market's revenue growth over the forecast period.
The current report Scope analyzes Delirium Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Delirium Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Delirium Market Analysis
Global Delirium Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Delirium Industry growth. Delirium market has been segmented with the help of its Disease Type, End-Use Distribution channel, and others. Delirium market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Disease Type Segment Analysis
According to Cognitive Market Research, the hyperactive delirium market category is in high demand. A variant of delirium known as hyperactive delirium is distinguished by agitation, restlessness, and increased motor activity. It is frequently more obvious and can present difficulties in managing and treating delirium. The need for hyperactive delirium therapies and therapeutic techniques is increasing as healthcare practitioners attempt to effectively manage the symptoms and improve patient outcomes.
The hypoactive delirium segment is an important part of the Delirium Market. The symptoms of hypoactive delirium include decreased motor activity, lethargy, and slower cognitive functions. Because of its modest symptoms, it is frequently misdiagnosed and missed.
- Hyperactive delirium
- Hypoactive delirium
- Mixed delirium
Delirium Market Share (%) by Disease Type in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Delirium Industry. Request a Free Sample PDF!
End-Use Segment Analysis
The hospitals category brought in the greatest money. Hospitals play an important role in delirium diagnosis, administration, and management. Medical personnel such as physicians, nurses, and specialists evaluate patients, offer medical therapies, and monitor the progression of delirium episodes in various settings.
According to Cognitive Market Research, the specialty clinic segment is rapidly expanding. These clinics offer specialized care and interventions for delirium patients, as well as individualized treatment regimens and expert support. The growing acknowledgment of delirium as a major healthcare concern has increased demand for these specialty clinics, resulting in their extraordinary expansion.
- Hospitals
- Speciality clinics
Delirium Market Share (%) by End-Use in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Delirium Distribution channel Segment Analysis
According to Cognitive Market Research, the Offline segment has the largest market share in the delirium market since it refers to non-digital or physical interventions and treatments for delirium management. This encompasses non-pharmacological therapy, environmental changes, and supportive care delivered in healthcare settings.
The online segment is a key part of the delirious market. It includes digital actions and tools that can help with delirium management and treatment. Online instructional resources, telemedicine consultations, virtual cognitive stimulation programs, and remote monitoring systems are examples of this.
- Offline
- Online
Delirium Route of administration Segment Analysis
The parenteral sector accounts for the majority of market share. Parenteral drugs are those that are supplied via methods other than the digestive tract, such as intravenous injections or infusions. These methods allow for rapid and direct medicine delivery, making them extremely helpful in treating delirium symptoms. Because of its capacity to deliver instant relief and exact dosing, the parenteral portion is preferred.
The oral segment is a significant part of the Market. Oral medicines are delivered and ingested through the mouth, making them a practical and extensively utilized technique of delirium management. They are simple to give and, in some situations, can be self-administered by patients.
- Oral
- Parenteral
- Others
Delirium Treatment Segment Analysis
According to Cognitive Market Research, the market was dominated by second-generation antipsychotics. Because these drugs have a lower affinity for dopamine receptors, their side effects will be decreased. This is why the market need for delirium management is expanding.
The first-generation antipsychotics sector is also a big market participant. For the treatment of delirium symptoms, first-generation antipsychotics, also known as conventional antipsychotics, have been widely employed. They act by inhibiting dopamine receptors in the brain, which helps to relieve delirium-related psychosis and agitation.
- Medication
- First-generation Antipsychotics
- Second-generation Antipsychotics
- Benzodiazepines
- Others
Delirium Dosage Form Segment Analysis
Tablets are the most popular form in the market. Tablets are a popular alternative for addressing a variety of disorders, including delirium, since they provide convenience, ease of administration, and a wide range of dose options. They are simply taken orally and are frequently self-administered by patients, providing for greater independence and therapeutic flexibility.
Injections are another popular method of dose on the market. Injections carry medication directly and quickly into the body, making them extremely helpful in the treatment of delirium and other medical problems. They are often given by healthcare experts and ensure proper dosing.
- Tablets
- Injections
- Others
Author's Detail
Manjiri KanhereSenior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Bio :
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Delirium Market is witnessing significant growth in the near future.
In 2023, the Hyperactive delirium segment accounted for noticeable share of global Delirium Market and is projected to experience significant growth in the near future.
The Hospitals segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Dr Franz Kohler Chemie GmbH , Teva pharmaceuticals and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions (FAQs)
The delirium industry has a global market value of $0.248 billion in 2022.
The global market is expected to grow at a CAGR of 6.10% during the projection period.
The region with the largest revenue share in the global market for delirium in 2022 was North America.
Over the coming years, Asia Pacific will see the fastest growth in the market for delirium.
In terms of revenue, the United States dominated the market for delirium in North America in 2022.
The main reasons influencing the growth of the delirium industry include geriatric population growth and rising prevalence of delirium in ICU patients.
The Offline market has the largest global share, broken down by component.
In 2022, the hospitals market held a sizeable market share in terms of service revenue.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Delirium Market
Latest Articles about Delirium Market
Delirium is a neurological illness that causes abnormalities in a persons mental capacity. It produces mental perplexity as well as emotional upheaval.
Sources from Pharma & Healthcare Industry
- https://en.wikipedia.org/wiki/American_Society_for_Pharmacy_Law
- https://en.wikipedia.org/wiki/American_Society_of_Consultant_Pharmacists
- https://en.wikipedia.org/wiki/American_Society_of_Health-System_Pharmacists
- https://www.apsm-uk.com/
- https://en.wikipedia.org/wiki/Australasian_College_of_Pharmacy
- https://en.wikipedia.org/wiki/American_Association_of_Colleges_of_Pharmacy
- https://en.wikipedia.org/wiki/American_College_of_Clinical_Pharmacy
- https://en.wikipedia.org/wiki/American_Pharmacists_Association
- https://www.bio.org/
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Association
- https://en.wikipedia.org/wiki/Canadian_Society_of_Hospital_Pharmacists
- https://en.wikipedia.org/wiki/Chinese_Pharmaceutical_Association
- https://en.wikipedia.org/wiki/American_Association_of_Psychiatric_Pharmacists
- https://en.wikipedia.org/wiki/Danish_Association_of_Pharmaconomists
- https://en.wikipedia.org/wiki/EPhEU
- https://www.fda.gov/
- https://www.gmc-uk.org/
- https://www.ifpma.org/
- https://www.fip.org/
- https://en.wikipedia.org/wiki/International_Pharmaceutical_Students%27_Federation
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- https://en.wikipedia.org/wiki/National_Pharmacy_Association
- https://en.wikipedia.org/wiki/Norwegian_Pharmacy_Association
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Journal#History
- https://en.wikipedia.org/wiki/Pakistan_Pharmacists_Association
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Mauritius
- https://en.wikipedia.org/wiki/Pharmaceutical_Group_of_the_European_Union
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Australia
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_New_Zealand
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Northern_Ireland
- https://en.wikipedia.org/wiki/Professional_Compounding_Centers_of_America
- https://en.wikipedia.org/wiki/Royal_Pharmaceutical_Society
- https://www.aaps.org/home
- https://www.bioindustry.org/
- https://www.controlledreleasesociety.org/
- https://www.efpia.eu/
- https://www.epemed.org/online/www/content/ENG/index.html
- https://icr-global.org/
- https://ispe.org/
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Israel
- https://www.phrma.org/
- https://en.wikipedia.org/wiki/The_Pharmacy_Guild_of_Australia
- https://en.wikipedia.org/wiki/The_Society_of_Hospital_Pharmacists_of_Australia
- https://en.wikipedia.org/wiki/Healthcare_industry
- https://www.pharma-iq.com/business-development/articles/top-50-pharmaceutical-blogs-and-publications
- https://www.pharmatimes.com/news
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967517/
- https://www.cbo.gov/publication/57126
- http://: https://www.who.int/tools/atc-ddd-toolkit/data
- https://www.oecd.org/els/health-systems/health-data.htm
- https://www.bls.gov/ooh/healthcare/home.htm
- https://data.worldbank.org/topic/8
- https://www.statnews.com/about/
- https://www.health.pa.gov/topics/HealthStatistics/Pages/health-statistics.aspx
- https://www.cdc.gov/nchs/index.htm
- https://www.aha.org/statistics/fast-facts-us-hospitals
- https://www.census.gov/library/publications/2021/demo/p60-274.html
- https://www.adb.org/what-we-do/sectors/health/main
Delirium Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Disease Type | Hyperactive delirium, Hypoactive delirium, Mixed delirium |
| End-Use | Hospitals, Speciality clinics |
| Distribution channel | Offline, Online |
| Route of administration | Oral, Parenteral, Others |
| Treatment | Medication, First-generation Antipsychotics, Second-generation Antipsychotics, Benzodiazepines, Others |
| Dosage Form | Tablets, Injections, Others |
| List of Competitors | Dr Franz Kohler Chemie GmbH, Gala BioPharma Ltd., Teva pharmaceuticals, Mylan N.V., Pfizer Inc., Regenstrief Institute Inc, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Bristol-Myers Squibb, Fraser Health, Zydus Cadila |
Expand All
This chapter will help you gain GLOBAL Market Analysis of Delirium. Further deep in this chapter, you will be able to review Global Delirium Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Delirium Revenue Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Delirium Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Delirium Revenue Market Size By Region
-
-
1.3 Global Delirium Market Size By Disease Type 2019 -2031
-
1.3.1 Hyperactive delirium Market Size
-
1.3.2 Hypoactive delirium Market Size
-
1.3.3 Mixed delirium Market Size
-
-
1.4 Global Delirium Market Size By End-Use 2019 -2031
-
1.4.1 Hospitals Market Size
-
1.4.2 Speciality clinics Market Size
-
-
1.5 Global Delirium Market Size By Distribution channel 2019 -2031
-
1.5.1 Offline Market Size
-
1.5.2 Online Market Size
-
-
1.6 Global Delirium Market Size By Route of administration for 2019 -2031
-
1.6.1 Oral Market Size
-
1.6.2 Parenteral Market Size
-
1.6.3 Others Market Size
-
-
1.7 Global Delirium Market Size By Treatment for 2019 -2031
-
1.7.1 Medication Market Size
-
1.7.2 First-generation Antipsychotics Market Size
-
1.7.3 Second-generation Antipsychotics Market Size
-
1.7.4 Benzodiazepines Market Size
-
1.7.5 Others Market Size
-
-
1.8 Global Delirium Market Size By Dosage Form for 2019 -2031
-
1.8.1 Tablets Market Size
-
1.8.2 Injections Market Size
-
1.8.3 Others Market Size
-
1.8.1 Tablets Market Size
-
1.8.2 Injections Market Size
-
1.8.3 Others Market Size
-
-
1.9 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.10 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.10.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.10.2 Global Market Revenue Split By Disease Type
-
1.10.3 Global Market Revenue Split By End-Use
-
1.10.4 Global Market Revenue Split By Distribution channel
-
1.10.5 Global Market Revenue Split By Route of administration
-
1.10.6 Global Market Revenue Split By Treatment
-
1.10.7 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
This chapter will help you gain North America Market Analysis of Delirium. Further deep in this chapter, you will be able to review North America Delirium Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
-
2.1 North America Delirium Market Size 2019 - 2031
-
2.1.1 North America Delirium Market Size By Country 2019 - 2031
-
2.1.2 North America Delirium Market Size by Disease Type 2019 -2031
-
2.1.2.1 North America Hyperactive delirium Market Size
-
2.1.2.2 North America Hypoactive delirium Market Size
-
2.1.2.3 North America Mixed delirium Market Size
-
-
2.1.3 North America Delirium Market Size by End-Use 2019 -2031
-
2.1.3.1 North America Hospitals Market Size
-
2.1.3.2 North America Speciality clinics Market Size
-
-
2.1.4 North America Delirium Market Size by Distribution channel 2019 -2031
-
2.1.4.1 North America Offline Market Size
-
2.1.4.2 North America Online Market Size
-
-
2.1.5 North America Delirium Market Size by Route of administration 2019 -2031
-
2.1.5.1 North America Oral Market Size
-
2.1.5.2 North America Parenteral Market Size
-
2.1.5.3 North America Others Market Size
-
-
2.1.6 North America Delirium Market Size by Treatment 2019 -2031
-
2.1.6.1 North America Medication Market Size
-
2.1.6.2 North America First-generation Antipsychotics Market Size
-
2.1.6.3 North America Second-generation Antipsychotics Market Size
-
2.1.6.4 North America Benzodiazepines Market Size
-
2.1.6.5 North America Others Market Size
-
-
2.1.7 North America Delirium Market Size by Dosage Form 2019 -2031
-
2.1.7.1 North America Tablets Market Size
-
2.1.7.2 North America Injections Market Size
-
2.1.7.3 North America Others Market Size
-
-
This chapter will help you gain Europe Market Analysis of Delirium. Further deep in this chapter, you will be able to review Europe Delirium Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
-
3.1 Europe Delirium Market Size 2019 - 2031
-
3.1.1 Europe Delirium Market Size By Country 2019 - 2031
-
3.1.2 Europe Delirium Market Size by Disease Type 2019 -2031
-
3.1.2.1 Europe Hyperactive delirium Market Size
-
3.1.2.2 Europe Hypoactive delirium Market Size
-
3.1.2.3 Europe Mixed delirium Market Size
-
-
3.1.3 Europe Delirium Market Size by End-Use 2019 -2031
-
3.1.3.1 Europe Hospitals Market Size
-
3.1.3.2 Europe Speciality clinics Market Size
-
-
3.1.4 Europe Delirium Market Size by Distribution channel 2019 -2031
-
3.1.4.1 Europe Offline Market Size
-
3.1.4.2 Europe Online Market Size
-
-
3.1.5 Europe Delirium Market Size by Route of administration 2019 -2031
-
3.1.5.1 Europe Oral Market Size
-
3.1.5.2 Europe Parenteral Market Size
-
3.1.5.3 Europe Others Market Size
-
-
3.1.6 Europe Delirium Market Size by Treatment 2019 -2031
-
3.1.6.1 Europe Medication Market Size
-
3.1.6.2 Europe First-generation Antipsychotics Market Size
-
3.1.6.3 Europe Second-generation Antipsychotics Market Size
-
3.1.6.4 Europe Benzodiazepines Market Size
-
3.1.6.5 Europe Others Market Size
-
-
3.1.7 Europe Delirium Market Size by Dosage Form 2019 -2031
-
3.1.7.1 Europe Tablets Market Size
-
3.1.7.2 Europe Injections Market Size
-
3.1.7.3 Europe Others Market Size
-
-
This chapter will help you gain Asia Pacific Market Analysis of Delirium. Further deep in this chapter, you will be able to review Asia Pacific Delirium Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Delirium Market Size 2019 - 2031
-
4.1.1 Asia Pacific Delirium Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Delirium Market Size by Disease Type 2019 -2031
-
4.1.2.1 Asia Pacific Hyperactive delirium Market Size
-
4.1.2.2 Asia Pacific Hypoactive delirium Market Size
-
4.1.2.3 Asia Pacific Mixed delirium Market Size
-
-
4.1.3 Asia Pacific Delirium Market Size by End-Use 2019 -2031
-
4.1.3.1 Asia Pacific Hospitals Market Size
-
4.1.3.2 Asia Pacific Speciality clinics Market Size
-
-
4.1.4 Asia Pacific Delirium Market Size by Distribution channel 2019 -2031
-
4.1.4.1 Asia Pacific Offline Market Size
-
4.1.4.2 Asia Pacific Online Market Size
-
-
4.1.5 Asia Pacific Delirium Market Size by Route of administration 2019 -2031
-
4.1.5.1 Asia Pacific Oral Market Size
-
4.1.5.2 Asia Pacific Parenteral Market Size
-
4.1.5.3 Asia Pacific Others Market Size
-
-
4.1.6 Asia Pacific Delirium Market Size by Treatment 2019 -2031
-
4.1.6.1 Asia Pacific Medication Market Size
-
4.1.6.2 Asia Pacific First-generation Antipsychotics Market Size
-
4.1.6.3 Asia Pacific Second-generation Antipsychotics Market Size
-
4.1.6.4 Asia Pacific Benzodiazepines Market Size
-
4.1.6.5 Asia Pacific Others Market Size
-
-
4.1.7 Asia Pacific Delirium Market Size by Dosage Form 2019 -2031
-
4.1.7.1 Asia Pacific Tablets Market Size
-
4.1.7.2 Asia Pacific Injections Market Size
-
4.1.7.3 Asia Pacific Others Market Size
-
-
This chapter will help you gain South America Market Analysis of Delirium. Further deep in this chapter, you will be able to review South America Delirium Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
-
5.1 South America Delirium Market Size 2019 - 2031
-
5.1.1 South America Delirium Market Size By Country 2019 - 2031
-
5.1.2 South America Delirium Market Size by Disease Type 2019 -2031
-
5.1.2.1 South America Hyperactive delirium Market Size
-
5.1.2.2 South America Hypoactive delirium Market Size
-
5.1.2.3 South America Mixed delirium Market Size
-
-
5.1.3 South America Delirium Market Size by End-Use 2019 -2031
-
5.1.3.1 South America Hospitals Market Size
-
5.1.3.2 South America Speciality clinics Market Size
-
-
5.1.4 South America Delirium Market Size by Distribution channel 2019 -2031
-
5.1.4.1 South America Offline Market Size
-
5.1.4.2 South America Online Market Size
-
-
5.1.5 South America Delirium Market Size by Route of administration 2019 -2031
-
5.1.5.1 South America Oral Market Size
-
5.1.5.2 South America Parenteral Market Size
-
5.1.5.3 South America Others Market Size
-
-
5.1.6 South America Delirium Market Size by Treatment 2019 -2031
-
5.1.6.1 South America Medication Market Size
-
5.1.6.2 South America First-generation Antipsychotics Market Size
-
5.1.6.3 South America Second-generation Antipsychotics Market Size
-
5.1.6.4 South America Benzodiazepines Market Size
-
5.1.6.5 South America Others Market Size
-
-
5.1.7 South America Delirium Market Size by Dosage Form 2019 -2031
-
5.1.7.1 South America Tablets Market Size
-
5.1.7.2 South America Injections Market Size
-
5.1.7.3 South America Others Market Size
-
-
This chapter will help you gain Middle East and Africa Market Analysis of Delirium. Further deep in this chapter, you will be able to review Middle East and Africa Delirium Market Split by various segments and Country Split.
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Delirium Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Delirium Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Delirium Market Size by Disease Type 2019 -2031
-
6.1.2.1 Middle East and Africa Hyperactive delirium Market Size
-
6.1.2.2 Middle East and Africa Hypoactive delirium Market Size
-
6.1.2.3 Middle East and Africa Mixed delirium Market Size
-
-
6.1.3 Middle East and Africa Delirium Market Size by End-Use 2019 -2031
-
6.1.3.1 Middle East and Africa Hospitals Market Size
-
6.1.3.2 Middle East and Africa Speciality clinics Market Size
-
-
6.1.4 Middle East and Africa Delirium Market Size by Distribution channel 2019 -2031
-
6.1.4.1 Middle East and Africa Offline Market Size
-
6.1.4.2 Middle East and Africa Online Market Size
-
-
6.1.5 Middle East and Africa Delirium Market Size by Route of administration 2019 -2031
-
6.1.5.1 Middle East and Africa Oral Market Size
-
6.1.5.2 Middle East and Africa Parenteral Market Size
-
6.1.5.3 Middle East and Africa Others Market Size
-
-
6.1.6 Middle East and Africa Delirium Market Size by Treatment 2019 -2031
-
6.1.6.1 Middle East and Africa Medication Market Size
-
6.1.6.2 Middle East and Africa First-generation Antipsychotics Market Size
-
6.1.6.3 Middle East and Africa Second-generation Antipsychotics Market Size
-
6.1.6.4 Middle East and Africa Benzodiazepines Market Size
-
6.1.6.5 Middle East and Africa Others Market Size
-
-
6.1.7 Middle East and Africa Delirium Market Size by Dosage Form 2019 -2031
-
6.1.7.1 Middle East and Africa Tablets Market Size
-
6.1.7.2 Middle East and Africa Injections Market Size
-
6.1.7.3 Middle East and Africa Others Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Delirium Market Size by Disease Type 2019 -2031
-
7.1.2 Country 1Delirium Market Size by End-Use 2019 -2031
-
7.1.3 Country 1Delirium Market Size by Distribution channel 2019 -2031
-
7.1.4 Country 1Delirium Market Size by Route of administration 2019 -2031
-
7.1.5 Country 1Delirium Market Size by Treatment 2019 -2031
-
7.1.6 Country 1Delirium Market Size by Dosage Form 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
This chapter provides an in-depth analysis of the market share among key competitors of Delirium. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Delirium Market Revenue and Share by Key Players
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Dr Franz Kohler Chemie GmbH
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Gala BioPharma Ltd.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Teva pharmaceuticals
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Mylan N.V.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Pfizer Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Regenstrief Institute Inc
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Novartis AG
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Otsuka Pharmaceutical Co. Ltd.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Bristol-Myers Squibb
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Fraser Health
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 Zydus Cadila
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Restraints
-
9.3 Market Trends
-
9.4 Market Opportunity
-
9.5 Technological Road Map (Subject to Data Availability)
-
9.6 Product Life Cycle (Subject to Data Availability)
-
9.7 Consumer Preference Analysis
-
9.8 Market Attractiveness Analysis
-
9.9 PESTEL Analysis
-
9.9.1 Political Factors
-
9.9.2 Economic Factors
-
9.9.3 Social Factors
-
9.9.4 Technological Factors
-
9.9.5 Legal Factors
-
9.9.6 Environmental Factors
-
-
9.10 Industrial Chain Analysis (Subject to Data Availability)
-
9.10.1 Industry Chain Analysis
-
9.10.2 Manufacturing Cost Analysis
-
9.10.3 Supply Side Analysis
-
9.10.3.1 Raw Material Analysis
-
9.10.3.2 Raw Material Procurement Analysis
-
9.10.3.3 Raw Material Price Trend Analysis
-
-
-
9.11 Porter’s Five Forces Analysis
-
9.11.1 Bargaining Power of Suppliers
-
9.11.2 Bargaining Power of Buyers
-
9.11.3 Threat of New Entrants
-
9.11.4 Threat of Substitutes
-
9.11.5 Degree of Competition
-
-
9.12 Patent Analysis (Subject to Data Availability)
-
9.13 ESG Analysis
Segmentation Disease Type Analysis 2019 -2031, will provide market size split by Disease Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Disease Type Analysis 2019 -2031
-
10.1 Hyperactive delirium
-
10.1.1 Global Delirium Revenue Market Size and Share by Hyperactive delirium 2019 -2031
-
-
10.2 Hypoactive delirium
-
10.2.1 Global Delirium Revenue Market Size and Share by Hypoactive delirium 2019 -2031
-
-
10.3 Mixed delirium
-
10.3.1 Global Delirium Revenue Market Size and Share by Mixed delirium 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by End-Use Analysis 2019 -2031
-
11.1 Hospitals
-
11.1.1 Global Delirium Revenue Market Size and Share by Hospitals 2019 - 2031
-
-
11.2 Speciality clinics
-
11.2.1 Global Delirium Revenue Market Size and Share by Speciality clinics 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Distribution channel Analysis 2019 -2031
-
12.1 Offline
-
12.1.1 Global Delirium Revenue Market Size and Share by Offline 2019 -2031
-
-
12.2 Online
-
12.2.1 Global Delirium Revenue Market Size and Share by Online 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Route of administration Analysis 2019 -2031
-
13.1 Oral
-
13.1.1 Global Delirium Revenue Market Size and Share by Oral 2019 -2031
-
-
13.2 Parenteral
-
13.2.1 Global Delirium Revenue Market Size and Share by Parenteral 2019 -2031
-
-
13.3 Others
-
13.3.1 Global Delirium Revenue Market Size and Share by Others 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by Treatment Analysis 2019 -2031
-
14.1 Medication
-
14.1.1 Global Delirium Revenue Market Size and Share by Medication 2019 -2031
-
-
14.2 First-generation Antipsychotics
-
14.2.1 Global Delirium Revenue Market Size and Share by First-generation Antipsychotics 2019 -2031
-
-
14.3 Second-generation Antipsychotics
-
14.3.1 Global Delirium Revenue Market Size and Share by Second-generation Antipsychotics 2019 -2031
-
-
14.4 Benzodiazepines
-
14.4.1 Global Delirium Revenue Market Size and Share by Benzodiazepines 2019 -2031
-
-
14.5 Others
-
14.5.1 Global Delirium Revenue Market Size and Share by Others 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 15 Market Split by Dosage Form Analysis 2019 -2031
-
15.1 Tablets
-
15.1.1 Global Delirium Revenue Market Size and Share by Tablets 2019 -2031
-
-
15.2 Injections
-
15.2.1 Global Delirium Revenue Market Size and Share by Injections 2019 -2031
-
-
15.3 Others
-
15.3.1 Global Delirium Revenue Market Size and Share by Others 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Delirium market
Chapter 16 Research Findings
-
16.1 Key Takeaways
-
16.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
16.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Market Timeline 2019 till 2031, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
Market Timeline 2019 till 2031, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
Research Methodology Implemented by Manjiri Kanhere and Team
- 1.1 Delirium Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Delirium Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Delirium Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Delirium Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Delirium Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Delirium Market
Key Questions Answered By Delirium Market Report 2024
| Why Hyperactive delirium have a significant impact on Delirium market? |
| What are the key factors affecting the Hyperactive delirium and Hypoactive delirium of Delirium Market? |
| What is the CAGR/Growth Rate of Hospitals during the forecast period? |
| By type, which segment accounted for largest share of the global Delirium Market? |
| Which region is expected to dominate the global Delirium Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
